do you have to inject bpc 157 BPC-157 Oral vs Injection: Benefits, Bioavailability & Recovery FDA advisory committee votes to

This may be caused by hyperinsulinaemia during the onset of the disease

Enhancement by BPC 157 of granulation tissue formation and collagen deposition

Its a devastating and entirely avoidable scenario

Side Effects & Mitigation GLOWs side-effect profile is driven mainly by its components known reactions in research settings

the clinical relevance of this finding in humans is unknown, and in UK and EU prescribing information this is noted as a precaution rather than a formal contraindication but individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) should discuss this with their doctor